Think. Connect. Build.

Texas is rapidly emerging as one of the most important innovation and business hubs in the United States — with a business-friendly environment, no state individual income tax, competitive operating costs compared with major coastal markets, and world-class research institutions.

What further distinguishes Texas is the scale of its public commitment to innovation. Through initiatives such as the Cancer Prevention and Research Institute of Texas (CPRIT) — a $6 billion initiative representing the largest state cancer research investment in U.S. history — and the newly established Dementia Prevention and Research Institute of Texas (DPRIT), backed by a $3 billion state research fund, Texas is making an extraordinary, long-term investment in life sciences, medical research, and commercialization.

Houston is home to the Texas Medical Center, the world's largest medical complex, while Dallas is home to UT Southwestern Medical Center, one of the nation's leading academic medical institutions. Together with Austin, San Antonio, and other rapidly growing innovation centers, these assets create a uniquely connected ecosystem where universities, healthcare institutions, startups, investors, corporations, and government-backed funding programs work together to translate scientific discoveries into real-world impact.

Japan is one of the United States' most important strategic and economic partners and a major source of investment, technology, and job creation in Texas. Over the past decade, Japanese companies have announced more than $14 billion in capital investment in Texas, making Japan the #1 source country for new jobs created by foreign direct investment in the state.

Beyond investment, Japan brings globally recognized strengths in healthcare and life sciences, pharmaceuticals and biotechnology, medical technology, advanced manufacturing, robotics, and precision engineering — supported by world-class corporations, universities, research institutions, and a sophisticated healthcare market.

Japan is also entering a new phase of healthcare innovation. Through national initiatives led by organizations such as AMED (Japan Agency for Medical Research and Development), the country is increasingly focused on translating scientific discoveries into commercial applications, supporting healthcare startups, and expanding Japanese medical innovation into global markets — particularly the United States.

This creates a powerful opportunity: Japan brings deep scientific expertise, technology, and industrial capabilities, while Texas provides capital, clinical infrastructure, entrepreneurial talent, and access to the world's largest healthcare market. By connecting these complementary strengths, J-THINK aims to create a new pathway for innovation to move between Japan and Texas — from research to commercialization, and from local discovery to global impact.